Shailender Bhatia, MD
Acting Instructor
Department of Medicine
Division of Oncology

Specialty / Expertise

Skin Cancers (Melanoma, Merkel Cell Cancer)
Kidney Cancers

Research Interests

Clinical trials in Melanoma, Renal Cell Cancers
Immunotherapy
Targeted Therapies

Current Research Projects


Research Staff

Training

Dr. Bhatia received his MD from All India Institute of Medical Sciences, New Delhi, India. He completed his Internal Medicine Residency at the University of Connecticut Health Center, Farmington CT. He was a Post-Doctoral Fellow in Hematology-Oncology at the University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA.

Selected Publications:

Bhatia S, Huber BR, Upton MP, Thompson JA. Inflammatory enteric neuropathy with severe constipation after ipilimumab treatment for melanoma. J Immunotherapy, 2008 in press.

Thompson JA, Curti BD, Redman BG, Bhatia S, Weber JS, Agarwala SS, Sievers EL, Hughes SD, Devries TA, Hausman DF. Phase I study of recombinant interleukin-21 in patients with metastatic melanoma and renal cell carcinoma. J Clin Oncol 2008 Apr 20;26(12):2034-2039.

Mann GN, Bhatia S, Thompson JA. Anorectal Melanoma. Gastrointestinal Oncology: A Critical MDT Approach, 2008 May.

Bhatia S, Curti BC, Gordon M, Quinn D, DeVries TA, Hunder N, Hausman DF, Thompson JA. Recombinant IL-21 in combination with sorafenib: Interim results from a phase I/II study in patients with metastatic renal cell cancer. 2008 ASCO

Bhatia S, Bauer F, Bilgrami S. Candidiasis - Associated Hemophagocyctic Lymphohistiocytosis in Patient Infected with Human Immunodeficiency Virus. Clin Infect Dis 2003 Dec 1;37(11):e161-6.


 

University of Washington
Seattle Cancer Care Alliance
Fred Hutchinson Cancer Research Center

 
line decor
  
line decor
 
 logo
 
 

 
 
 
 

 

 

 

Contact Information:

Seattle Cancer Care Alliance
825 Eastlake Ave E
Seattle, WA 98109

Admin Contact:

Gathigi Gishuru